Enthera Srl:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Enthera Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11135
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enthera Srl (Enthera), a subsidiary of BiovelocITA Srl, is a biotechnology company, which strives to discover novel medicines for the treatment of diabetes and related gastrointestinal disorders. Gastrointestinal symptoms such as diarrhea and abdominal pain among diabetics are referred to as diabetic enteropathy (DE). The company discovered that in such diabetic patients, insulin-like growth factor binding protein-3 (IGFBP3) is produced in large quantities by the liver and it leads to dysfunction of the intestinal mucosa, causing DE. Enthera expects its findings to result in the development of medical treatment for intestinal disorders, and diabetic complications. The company works in partnership with San Raffaele Hospital, and IFOM (FIRC Institute of Molecular Oncology). Enthera is headquartered in Milano, Lombardia, Italy.

Enthera Srl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enthera Srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Enthera Srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Enthera Srl, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Enthera Raises USD4.7 Million in Seed Financing 10
Licensing Agreements 11
Enthera Enters into Licensing Agreement with Trianni 11
Enthera Enters into Licensing Agreement with San Raffaele Hospital 12
Enthera Srl – Key Competitors 13
Enthera Srl – Key Employees 14
Enthera Srl – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Enthera Srl, Pharmaceuticals & Healthcare, Key Facts 2
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enthera Srl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enthera Srl, Deals By Therapy Area, 2012 to YTD 2018 8
Enthera Srl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Enthera Raises USD4.7 Million in Seed Financing 10
Enthera Enters into Licensing Agreement with Trianni 11
Enthera Enters into Licensing Agreement with San Raffaele Hospital 12
Enthera Srl, Key Competitors 13
Enthera Srl, Key Employees 14

List of Figures
Enthera Srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enthera Srl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enthera Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Enthera Srl:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AJ Lucas Group Ltd (AJL):企業の財務・戦略的SWOT分析
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Deloitte Touche Tohmatsu Ltd:企業の戦略的SWOT分析
    Deloitte Touche Tohmatsu Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Pacific Mutual Holding Company:企業の戦略的SWOT分析
    Pacific Mutual Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • PetSmart Inc:企業の戦略・SWOT・財務分析
    PetSmart Inc - Strategy, SWOT and Corporate Finance Report Summary PetSmart Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Veran Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Veran Medical Technologies Inc (Veran) is a medical device company that develops products for minimally invasive delivery of interventional oncology therapies. The company provides endobronchial products such as SpiN thoracic navigation system, Always-On tip tracked instruments, SpiNPerc and …
  • Costcutter Supermarkets Group Ltd:企業の戦略・SWOT・財務分析
    Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Med BioGene Inc (MBI)-医療機器分野:企業M&A・提携分析
    Summary Med BioGene Inc (Med BioGene) is a life sciences company, which develops and commercializes genome-based clinical laboratory diagnostic tests. The company’s lead test under development, GeneFx Lung formerly LungExpress Dx, is a proprietary gene expression based test. Its GeneFx Lung test is …
  • Celonic AG-製薬・医療分野:企業M&A・提携分析
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that provides contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of ac …
  • Petroleos de Venezuela SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • University of California Los Angeles-製薬・医療分野:企業M&A・提携分析
    Summary University of California Los Angeles (UCLA) a subsidiary of University of California is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, graduat …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Biofrontera AG (B8F):製薬・医療:M&Aディール及び事業提携情報
    Summary Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic kerat …
  • Kirby Corporation:企業の戦略・SWOT・財務情報
    Kirby Corporation - Strategy, SWOT and Corporate Finance Report Summary Kirby Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Thundelarra Ltd (THX):企業の財務・戦略的SWOT分析
    Summary Thundelarra Ltd (Thundelarra) is a mining and mineral exploration company. The company acquires, explores and develops lead, zinc, silver, nickel, graphite, copper, gold and uranium prospects in Western Australia and the Northern Territory. Its projects include Red Bore Copper-Gold Project, …
  • Quorum Business Solutions Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Quorum Business Solutions Inc (QBS) is a technology company that develops, implements, and supports software solutions. The company offers software in the areas of accounting; transactions and logistics management; land, property and right of way management; liquid and gas measurement; energ …
  • Sohar Power Company SAOG:発電所・企業SWOT分析
    Sohar Power Company SAOG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Harris Corp (HRS):企業の財務・戦略的SWOT分析
    Harris Corp (HRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hyundai Steel Co:企業の戦略・SWOT・財務情報
    Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report Summary Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • XsunX Inc (XSNX):企業の財務・戦略的SWOT分析
    XsunX Inc (XSNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • North Asia Strategic Holdings Limited:企業の戦略・SWOT・財務分析
    North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆